NCT00185003View on ClinicalTrials.gov

Blockade of Vascular Potassium Channels During Human Endotoxemia

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Endotoxemia
Interventions
DRUG

endotoxin

DRUG

Potassium channel blockers: TEA, Quinin, Tolbutamide

DRUG

L-NMMA

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Radboud University Medical Center

OTHER

NCT00185003 - Blockade of Vascular Potassium Channels During Human Endotoxemia | Biotech Hunter | Biotech Hunter